The identification of familial, AD-linked mutations in the genes for amyloid-β precursor protein (APP) and presenilin (PS1 and PS2) associated with deregulation of Aβ peptide production suggests that APP metabolism is at the heart of the disease process through the statement of the amyloid cascade hypothesis [2]. The gene discussed is APP; the disease is Alzheimer disease.